30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2011 To Date (July 2011): Merger & Acquisition Activity in Orthopaedics and Spine


PROCHON BIOTECH acquired by HISTOGENICS in stock for stock exchange
* Following transaction, Histogenics brought in >$34MM in equity and debt financing
* Will develop NeoCart autologous knee cartilage regeneration system (in Phase III trials); BioCart growth factor plus scaffold for knee cartilage repair (Phase II trials)